Bristol Myers Squibb Company

Many executives delivered 'bang for the buck'

2005-05-15 00:00:00

For 2004, a year that saw the shares of T. Rowe Price Group Inc. surge more than 31 percent, company chief executive George A. Roche received a more modest 21.7 percent bump in his compensation - just about all from performance bonuses. In short, a half-...

Ex-ImClone CEO: A very social scientist

2002-06-27 00:00:00

It was quite a party: Celebrity guests like Martha Stewart and Mick Jagger mingled with business tycoons around bowls of caviar in an art-adorned Soho loft. Some guests saw the December affair as emblematic of the host's generosity, and that it reflected...

A chronology of ImClone events

2002-10-15 00:00:00

Here is a chronology of events in the ImClone Systems Inc. case: 1986: Samuel D. Waksal founds biopharmaceutical company ImClone Systems Inc., begins operations in a converted shoe factory in Manhattan. The company focuses on immunology-based...

Samuel Waksal in brief

2002-10-15 00:00:00

Age: 55. Born in Paris and moved with his family in the early 1950s to Dayton, Ohio. Residence: SoHo loft in Manhattan, two homes in the Hamptons, on Long Island. Career: Scientist and researcher, with a doctorate in immunobiology. Undergraduate and...

Md. bill targets gifts to doctors

2003-03-03 00:00:00

Maryland lawmakers are considering clamping down on the fancy meals, theater tickets and expensive trips lavished on doctors by pharmaceutical companies trying to persuade health care professionals to prescribe their medications. "The system bothers me,"...

Assemblyman Hall attended Kentucky Derby as fact-finder, fundraiser

2012-05-11 16:38:44

UPDATE 1-FDA panel recommends Gilead's Quad for HIV

2012-05-11 12:03:08

(Adds details and background) WASHINGTON, May 11 (Reuters) - A U.S. Food and Drug Administration panel of outside experts on Friday recommended the use of Gilead Sciences Inc's Quad pill for untreated HIV patients. The FDA advisory committee voted 13-...

UPDATE 2-FDA panel recommends Gilead's Quad for HIV

2012-05-11 12:36:06

* FDA panel OKs Quad but urges monitoring, study * Agency to decide on approval by Aug. 27 * HIV activists warn on effects of rising drug prices (Updates throughout with details, quotes, background) By David Morgan WASHINGTON, May 11 (Reuters) - A U....

UPDATE 3-FDA panel recommends Gilead's Quad for HIV

2012-05-11 14:00:10

* FDA panel OKs Quad but urges monitoring, study * Agency to decide on approval by Aug. 27 * HIV activists warn on effects of rising drug prices (Adds Wall St reaction in paragraphs 8-9; updates share price) By David Morgan WASHINGTON, May 11...

FDA panel recommends Gilead's Quad for HIV

2012-05-11 14:10:00

WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts on Friday recommended the use of Gilead Sciences Inc's Quad pill for untreated HIV patients. The FDA advisory committee voted 13-1 to endorse the four-drugs-in-one...

RPT-INSIGHT-Training immune system to fight cancer comes of age

2012-05-07 04:01:03

* Scores of cancer immunotherapies undergoing clinical trials * Significant data from many due over next year * Theory of using immune system to fight cancer dates to 1890s * Immunotherapies may extend survival without shrinking tumors By Bill Berkrot...

RPT-FACTBOX-Drugmakers on the cusp of new immunotherapy era

2012-05-07 04:01:03

May 7 (Reuters) - Global drugmakers and tiny biotechs are developing promising cancer vaccines and other treatments that use the immune system to attack tumors. Leading doctors in the field believe the next 18 months could finally prove the broader value...

California Insurance Commissioner Dave Jones announces the lawsuit against Bristol-Myers Squibb .

2011-03-18 00:00:00